The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of ISPH

Document Sample
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of ISPH Powered By Docstoc
					The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into
Possible Breaches of Fiduciary Duty by the Board of ISPH

Levi & Korsinsky is investigating the Board of Directors of Inspire
Pharmaceuticals, Inc. (“Inspire” or the “Company”) (Nasdaq: ISPH) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Merck (NYSE: MRK).

New York, NY, April 06, 2011 -- Levi & Korsinsky is investigating the
Board of Directors of Inspire Pharmaceuticals, Inc. (“Inspire” or the
“Company”) (Nasdaq: ISPH) for possible breaches of fiduciary duty and
other violations of state law in connection with the sale of the Company
to Merck (NYSE: MRK). Under the terms of the transaction, Inspire
shareholders will receive $5.00 in cash per share of Inspire outstanding
stock they own. The transaction has a total value of approximately $430
million.

Click here to learn how to join the action: http://www.zlk.com/inspire-
pharmaceuticals-isph.html, or call: 877-363-5972.

The investigation concerns whether the Inspire Board of Directors
breached their fiduciary duties to Inspire stockholders by failing to
adequately shop the Company before entering into this transaction and
whether Merck is underpaying for Inspire shares, thus unlawfully harming
Inspire stockholders. In particular, the mean price target set by five
analysts for Inspire stock is $5.95 per share and at least one analyst
set a price target of $10.00 per share.

If you own common stock in Inspire and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-
5972, or visit http://www.zlk.com/inspire-pharmaceuticals-isph.html.

Levi & Korsinsky has expertise in prosecuting investor securities
litigation and extensive experience in actions involving financial fraud
and represents investors throughout the nation, concentrating its
practice in securities and shareholder litigation. The attorneys at Levi
& Korsinsky have been appointed by numerous courts throughout the country
to serve as lead counsel on behalf of shareholders in major litigations
involving mergers and acquisitions. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.

Contact: Levi & Korsinsky, LLP, Joseph Levi, Esq., Eduard Korsinsky,
Esq., 30 Broad Street - 15th Floor, New York, NY 10004, Tel: (212) 363-
7500, Toll Free: (877) 363-5972, Fax: (212) 363-7171, www.zlk.com

Contact:
Joanna Chlebus
Levi & Korsinsky, LLP
30 Broad St, 15th Floor
New York, NY 10004
212-363-7500
jchlebus@zlk.com
http://www.zlk.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:63
posted:4/6/2011
language:English
pages:2
Description: Levi & Korsinsky is investigating the Board of Directors of Inspire Pharmaceuticals, Inc. (“Inspire” or the “Company”) (Nasdaq: ISPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Merck (NYSE: MRK).